Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report

A 59-year-old Japanese woman with a 22-year history of long-term hemodialysis was admitted to our hospital for further examination of hyperglycemia and anemia. Five months before hospitalization, her fasting plasma glucose value was 99 mg/dL and her glycated hemoglobin was 5.7%. On admission, her fa...

Full description

Bibliographic Details
Main Authors: Yusuke Yoshimura, Tatsuya Suwabe, Daisuke Ikuma, Yuki Oba, Masayuki Yamanouchi, Akinari Sekine, Hiroki Mizuno, Eiko Hasegawa, Junichi Hoshino, Kei Kono, Keiichi Kinowaki, Kenichi Ohashi, Naoki Sawa, Yoshifumi Ubara
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Kidney Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059522000917
_version_ 1818546937567117312
author Yusuke Yoshimura
Tatsuya Suwabe
Daisuke Ikuma
Yuki Oba
Masayuki Yamanouchi
Akinari Sekine
Hiroki Mizuno
Eiko Hasegawa
Junichi Hoshino
Kei Kono
Keiichi Kinowaki
Kenichi Ohashi
Naoki Sawa
Yoshifumi Ubara
author_facet Yusuke Yoshimura
Tatsuya Suwabe
Daisuke Ikuma
Yuki Oba
Masayuki Yamanouchi
Akinari Sekine
Hiroki Mizuno
Eiko Hasegawa
Junichi Hoshino
Kei Kono
Keiichi Kinowaki
Kenichi Ohashi
Naoki Sawa
Yoshifumi Ubara
author_sort Yusuke Yoshimura
collection DOAJ
description A 59-year-old Japanese woman with a 22-year history of long-term hemodialysis was admitted to our hospital for further examination of hyperglycemia and anemia. Five months before hospitalization, her fasting plasma glucose value was 99 mg/dL and her glycated hemoglobin was 5.7%. On admission, her fasting plasma glucose value was 873 mg/dL, glycated hemoglobin was 16.2%, C-peptide reactivity was 22.3 ng/mL (reference range, 0.5-3.0), and homeostasis model assessment of insulin resistance (HOMA-IR) was 10.6 (reference range, <2.0); the high HOMA-IR indicated high insulin resistance. Intensive insulin therapy was started for hyperglycemia, which required more than 40 units/day. Computed tomography showed a hypervascular lesion 2.2 cm in diameter on the right kidney; therefore, right nephrectomy was performed. Complete resection was confirmed, and the lesion was diagnosed as a clear cell type of renal cell carcinoma (RCC). Immediately after nephrectomy, glycemic control normalized and administration of insulin was discontinued. Fourteen days after nephrectomy, the HOMA-IR decreased to 2.96. RCC that develops in patients receiving long-term hemodialysis has been reported to be dialysis-related RCC, but there have been no reports suggesting a relationship between dialysis-related RCC and diabetes. To our knowledge, this is the first report of RCC presenting with the paraneoplastic syndrome of acute-onset diabetes because of insulin resistance.
first_indexed 2024-12-12T07:59:54Z
format Article
id doaj.art-067755d8feb444ed96fa57e09ae397c8
institution Directory Open Access Journal
issn 2590-0595
language English
last_indexed 2024-12-12T07:59:54Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Kidney Medicine
spelling doaj.art-067755d8feb444ed96fa57e09ae397c82022-12-22T00:32:11ZengElsevierKidney Medicine2590-05952022-06-0146100477Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case ReportYusuke Yoshimura0Tatsuya Suwabe1Daisuke Ikuma2Yuki Oba3Masayuki Yamanouchi4Akinari Sekine5Hiroki Mizuno6Eiko Hasegawa7Junichi Hoshino8Kei Kono9Keiichi Kinowaki10Kenichi Ohashi11Naoki Sawa12Yoshifumi Ubara13Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Address for Correspondence: Yusuke Yoshimura, MD, Nephrology Center, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, JapanDepartment of Pathology, Toranomon Hospital, Tokyo, JapanDepartment of Pathology, Toranomon Hospital, Tokyo, JapanDepartment of Pathology, Toranomon Hospital, Tokyo, Japan; Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, JapanNephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, JapanA 59-year-old Japanese woman with a 22-year history of long-term hemodialysis was admitted to our hospital for further examination of hyperglycemia and anemia. Five months before hospitalization, her fasting plasma glucose value was 99 mg/dL and her glycated hemoglobin was 5.7%. On admission, her fasting plasma glucose value was 873 mg/dL, glycated hemoglobin was 16.2%, C-peptide reactivity was 22.3 ng/mL (reference range, 0.5-3.0), and homeostasis model assessment of insulin resistance (HOMA-IR) was 10.6 (reference range, <2.0); the high HOMA-IR indicated high insulin resistance. Intensive insulin therapy was started for hyperglycemia, which required more than 40 units/day. Computed tomography showed a hypervascular lesion 2.2 cm in diameter on the right kidney; therefore, right nephrectomy was performed. Complete resection was confirmed, and the lesion was diagnosed as a clear cell type of renal cell carcinoma (RCC). Immediately after nephrectomy, glycemic control normalized and administration of insulin was discontinued. Fourteen days after nephrectomy, the HOMA-IR decreased to 2.96. RCC that develops in patients receiving long-term hemodialysis has been reported to be dialysis-related RCC, but there have been no reports suggesting a relationship between dialysis-related RCC and diabetes. To our knowledge, this is the first report of RCC presenting with the paraneoplastic syndrome of acute-onset diabetes because of insulin resistance.http://www.sciencedirect.com/science/article/pii/S2590059522000917Acute-onset diabetesinsulin resistancehomeostasis model assessment of insulin resistanceparaneoplastic syndromesrenal cell carcinoma
spellingShingle Yusuke Yoshimura
Tatsuya Suwabe
Daisuke Ikuma
Yuki Oba
Masayuki Yamanouchi
Akinari Sekine
Hiroki Mizuno
Eiko Hasegawa
Junichi Hoshino
Kei Kono
Keiichi Kinowaki
Kenichi Ohashi
Naoki Sawa
Yoshifumi Ubara
Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report
Kidney Medicine
Acute-onset diabetes
insulin resistance
homeostasis model assessment of insulin resistance
paraneoplastic syndromes
renal cell carcinoma
title Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report
title_full Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report
title_fullStr Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report
title_full_unstemmed Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report
title_short Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report
title_sort renal cell carcinoma associated diabetes mellitus due to paraneoplastic syndrome in maintenance hemodialysis a case report
topic Acute-onset diabetes
insulin resistance
homeostasis model assessment of insulin resistance
paraneoplastic syndromes
renal cell carcinoma
url http://www.sciencedirect.com/science/article/pii/S2590059522000917
work_keys_str_mv AT yusukeyoshimura renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT tatsuyasuwabe renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT daisukeikuma renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT yukioba renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT masayukiyamanouchi renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT akinarisekine renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT hirokimizuno renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT eikohasegawa renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT junichihoshino renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT keikono renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT keiichikinowaki renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT kenichiohashi renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT naokisawa renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport
AT yoshifumiubara renalcellcarcinomaassociateddiabetesmellitusduetoparaneoplasticsyndromeinmaintenancehemodialysisacasereport